Alpha 2.0
Login Register
» Authors » Hubert J Vesselle

Hubert J Vesselle

Explore the profile of Hubert J Vesselle including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 210
Followers 0
Related Specialties
Radiology
Oncology
Biophysics
Top 10 Co-Authors
Stephen R Bowen
Robert S Miyaoka
Jing Zeng
Paul E Kinahan
Ramesh Rengan
Smith Apisarnthanarax
Daniel S Hippe
Matthew J Nyflot
Tobias R Chapman
Renato G Martins
Published In
Int J Radiat Oncol Biol Phys
Med Phys
EJNMMI Res
Radiother Oncol
Adv Radiat Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Independent association of metabolic tumor response on FDG-PET with pulmonary toxicity following risk-adaptive chemoradiation for unresectable non-small cell lung cancer: Inherent radiosensitivity or immune response?
Gates E, Hippe D, Vesselle H, Zeng J, Bowen S
Radiother Oncol . 2023 May; 185:109720. PMID: 37244360
Background: In the context of a phase II trial of risk-adaptive chemoradiation, we evaluated whether tumor metabolic response could serve as a correlate of treatment sensitivity and toxicity. Methods: Forty-five...
2.
Utilizing Clinical Trial Data to Assess Timing of Surgical Treatment for Emphysema Patients
Alimohammadi M, Chaovalitwongse W, Vesselle H, Zhang S
Med Decis Making . 2022 Dec; 43(1):110-124. PMID: 36484571
Background: Lung volume reduction surgery (LVRS) and medical therapy are 2 available treatment options in dealing with severe emphysema, which is a chronic lung disease. However, or there are currently...
3.
Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?
Thomas H, Hippe D, Forouzannezhad P, Sasidharan B, Kinahan P, Miyaoka R, et al.
Discov Oncol . 2022 Sep; 13(1):85. PMID: 36048266
Background: Patients undergoing chemoradiation and immune checkpoint inhibitor (ICI) therapy for locally advanced non-small cell lung cancer (NSCLC) experience pulmonary toxicity at higher rates than historical reports. Identifying biomarkers beyond...
4.
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer
Bowen S, Hippe D, Thomas H, Sasidharan B, Lampe P, Baik C, et al.
Adv Radiat Oncol . 2022 Apr; 7(2):100857. PMID: 35387421
Purpose: We sought to examine the prognostic value of fluorodeoxyglucose-positron emission tomography (PET) imaging during chemoradiation for unresectable non-small cell lung cancer for survival and hypothesized that tumor PET response...
5.
Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer
Eaton K, Romine P, Martins R, Leblond A, Carr L, Vesselle H
Cureus . 2021 Nov; 13(10):e18804. PMID: 34796077
Objectives The change in tumor fluorodeoxyglucose (FDG) uptake by positron emission tomography (PET) scan after one cycle of platinum-based chemotherapy has been shown to predict progression-free and overall survival (PFS...
6.
Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer
Horn K, Thomas H, Vesselle H, Kinahan P, Miyaoka R, Rengan R, et al.
Clin Nucl Med . 2021 Jun; 46(11):861-871. PMID: 34172602
Purpose Of The Report: We evaluated the reliability of 18F-FDG PET imaging biomarkers to classify early response status across observers, scanners, and reconstruction algorithms in support of biologically adaptive radiation...
7.
Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer
Duan C, Chaovalitwongse W, Bai F, Hippe D, Wang S, Thammasorn P, et al.
Phys Med Biol . 2020 Oct; 65(20):205007. PMID: 33027064
We investigated the sensitivity of regional tumor response prediction to variability in voxel clustering techniques, imaging features, and machine learning algorithms in 25 patients with locally advanced non-small cell lung...
8.
Development and testing of SPECT/CT lung phantoms made from expanding polyurethane foam
Lehnert A, Hunter W, McDougald W, Harrison R, Lewellen T, Vesselle H, et al.
Med Phys . 2019 Sep; 46(12):5593-5601. PMID: 31536643
Purpose: Currently, single-photon emission computed tomography (SPECT)/computed tomography (CT) lung phantoms are commonly constructed using polystyrene beads and interstitial radioactive water. However, this approach often results in a phantom with...
9.
Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapy
Thomas H, Zeng J, Lee Jr H, Sasidharan B, Kinahan P, Miyaoka R, et al.
Br J Radiol . 2019 Aug; 92(1103):20190174. PMID: 31364397
Objective: The effect of functional lung avoidance planning on radiation dose-dependent changes in regional lung perfusion is unknown. We characterized dose-perfusion response on longitudinal perfusion single photon emission computed tomography...
10.
Voxel Forecast for Precision Oncology: Predicting Spatially Variant and Multiscale Cancer Therapy Response on Longitudinal Quantitative Molecular Imaging
Bowen S, Hippe D, Chaovalitwongse W, Duan C, Thammasorn P, Liu X, et al.
Clin Cancer Res . 2019 May; 25(16):5027-5037. PMID: 31142507
Purpose: Prediction of spatially variant response to cancer therapies can inform risk-adaptive management within precision oncology. We developed the "Voxel Forecast" multiscale regression framework for predicting spatially variant tumor response...